Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Clevidipine vs Urapidil for BP control in ICH
NCT03300479Phase 4Withdrawn
- Sponsor
- University of Zurich
- Start
- Jun 2017
- Primary completion
- May 2021
- Countries
- 1
01
Overview
A Phase 4 trial of clevidipine in intracerebral hemorrhage (ICH), sponsored by University of Zurich. Planned start Jun 2017; status: withdrawn.
02
Drugs
clevidipine
03
Conditions
intracerebral hemorrhage (ICH)
Beyond the preview
Go deeper on NCT03300479.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03300479.